Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytek Biosciences Inc (NQ: CTKB ) 5.650 +0.420 (+8.03%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 788,639 Open 5.300 Bid (Size) 5.310 (1) Ask (Size) 5.700 (301) Prev. Close 5.230 Today's Range 5.200 - 5.705 52wk Range 3.800 - 9.870 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility August 21, 2024 Certification Emphasizes Unwavering Commitment to Quality and Is an Essential Step for U.S. Clinical Market Entry From Cytek Biosciences, Inc. Via GlobeNewswire CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024 August 06, 2024 CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD -36.30% -36.30% 1 Month -10.03% -10.03% 3 Month -5.20% -5.20% 6 Month -35.21% -35.21% 1 Year -25.46% -25.46% More News Read More Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm July 30, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire The Latest Analyst Ratings for Cytek Biosciences December 14, 2023 Via Benzinga Cytek Biosciences Announces $50 Million Stock Repurchase Program June 06, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference May 30, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China May 28, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems May 20, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire CTKB Stock Earnings: Cytek Biosciences Misses EPS, Beats Revenue for Q1 2024 May 08, 2024 Via InvestorPlace Cytek Biosciences Reports First Quarter 2024 Financial Results May 08, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe April 30, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024 April 29, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023 March 27, 2024 Via InvestorPlace Cytek® Biosciences Names William McCombe Chief Financial Officer March 19, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions March 07, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday March 04, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Via Benzinga Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook February 28, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Participate in Upcoming Investor Conferences February 07, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 February 07, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries January 17, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results January 08, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference December 28, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry December 21, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says December 14, 2023 Via Benzinga Topics Supply Chain Exposures Supply Chain Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
